Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | VAV3 |
| Upstream (Parents) |
|---|
| (<<) RNF43 → VAV3 |
| (<<) C13orf23 → VAV3 |
| (<<) PLAGL2 → VAV3 |
| (<<) DDX27 → VAV3 |
| Downstream (Children) |
|---|
| VAV3 → APOLD1 (>>) |
| VAV3 → GABRA2 (>>) |
| VAV3 → CDK5R1 (>>) |
| VAV3 → H2AFJ (>>) |
| VAV3 → C10orf116 (>>) |
| VAV3 → MYO15B (>>) |
| VAV3 → BAGE (>>) |
| VAV3 → NEU1 (>>) |
| VAV3 → RPA4 (>>) |
| VAV3 → NRXN3 (>>) |
| VAV3 → ID2B (>>) |
| VAV3 → MARK1 (>>) |
| VAV3 → CHST4 (>>) |
| VAV3 → CAB39L (>>) |
